CD207 and neoplasm: A recent effort to identify the various myeloid cell types within a transplantable murine melanoma model demonstrated that the CD103+ DC subset, which most likely includes Langerin+ dermal DC, was superior over CD11b+CD103neg DC in cross-presenting tumor antigens (174).